{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T20:50:04Z","timestamp":1778273404009,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Kirstin Diehl-Stiftung"},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002714","name":"Albert-Ludwigs-Universit\u00e4t Freiburg","doi-asserted-by":"publisher","award":["Publication fee"],"award-info":[{"award-number":["Publication fee"]}],"id":[{"id":"10.13039\/501100002714","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This pilot trial aimed to investigate whether modified short-term fasting (mSTF) reduces the incidence of chemotherapy-induced toxicities and whether an initial ketogenic diet (KD) as fasting supportive diet reduces fasting-related discomfort and improves the compliance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this controlled cross-over trial, gynaecologic cancer patients undergoing chemotherapy with a minimum of 4\u2009cycles fasted for 96\u2009h during half of their chemotherapy cycles and consumed a normocaloric diet during the other chemotherapy cycles. The caloric intake during mSTF was restricted to 25% of each patient\u2019s daily requirement. In addition, half of the patients should eat a 6-day normocaloric KD prior to each mSTF period to investigate a KD\u2019s hunger-suppression effect. Chemotherapy-induced toxicities, fasting-related discomfort, body composition, quality of life, laboratory values, and compliance were assessed at each chemotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Thirty patients aged 30\u201374\u2009years (median 54\u2009years) completed the study. During mSTF the frequency and severity score of stomatitis [\u2212\u20090.16\u2009\u00b1\u20090.06; 95% CI -0.28 - (\u2212\u20090.03);\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.013], headaches [\u2212\u20091.80\u2009\u00b1\u20090.55; 95% CI -2.89 \u2013 (\u2212\u20090.71);\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.002], weakness [\u2212\u20091.99\u2009\u00b1\u20090.87; 95% CI -3.72 \u2013 (\u2212\u20090.26);\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.024] and the total toxicities\u2019 score were significantly reduced [\u2212\u200910.36\u2009\u00b1\u20094.44; 95% CI -19.22 - (\u2212\u20091.50);\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.023]. We also observed significantly fewer chemotherapy postponements post-mSTF, reflecting improved tolerance of chemotherapy [\u2212\u20090.80\u2009\u00b1\u20090.37; 95% CI -1.53 \u2013 (\u2212\u20090.06);\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.034]. A significant reduction in mean body weight by \u2212\u20090.79\u2009\u00b1\u20091.47\u2009kg during mSTF was not compensated and remained until study\u2019s conclusion (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.005). On average, Insulin [\u2212\u2009169.4\u2009\u00b1\u200944.1; 95% CI -257.1 \u2013 (\u2212\u200981.8);\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001] and Insulin-like growth factor 1 levels [\u2212\u200933.3\u2009\u00b1\u20095.4; 95% CI -44.1 \u2013 (\u2212\u200922.5);\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001] dropped significantly during fasting. The KD as a fasting supportive diet neither reduced fasting-related discomfort nor improved compliance of our fasting regimen.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>MSTF is safe and feasible in gynaecologic cancer patients. Our results indicate that mSTF during chemotherapy can reduce chemotherapy-induced toxicities and enhance the tolerance of chemotherapy. Larger clinical trials are required to recommend mSTF for cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      germanctr.de:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.drks.de\/drks_web\/navigate.do?navigationId=trial.HTML&amp;TRIAL_ID=DRKS00011610\">DRKS00011610<\/jats:ext-link>\n                      , registered 30 January, 2017.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-020-07041-7","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T06:02:55Z","timestamp":1592805775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Impact of modified short-term fasting and its combination with a fasting supportive diet during chemotherapy on the incidence and severity of chemotherapy-induced toxicities in cancer patients - a controlled cross-over pilot study"],"prefix":"10.1186","volume":"20","author":[{"given":"Stefanie","family":"Zorn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine","family":"Ehret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Sch\u00e4uble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beate","family":"Rautenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Ihorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3805-8123","authenticated-orcid":false,"given":"Hartmut","family":"Bertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Urbain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Raynor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,22]]},"reference":[{"issue":"6","key":"7041_CR1","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1159\/000357765","volume":"20","author":"A Michalsen","year":"2013","unstructured":"Michalsen A, Li C. Fasting therapy for treating and preventing disease - current state of evidence. Forsch Komplement\u00e4rmedizin Res Complement Med. 2013;20(6):444\u201353.","journal-title":"Forsch Komplement\u00e4rmedizin Res Complement Med."},{"issue":"10","key":"7041_CR2","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.exger.2013.02.016","volume":"48","author":"S Brandhorst","year":"2013","unstructured":"Brandhorst S, Wei M, Hwang S, Morgan TE, Longo VD. Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression. Exp Gerontol. 2013;48(10):1120\u20138.","journal-title":"Exp Gerontol"},{"issue":"9","key":"7041_CR3","doi-asserted-by":"crossref","first-page":"e44603","DOI":"10.1371\/journal.pone.0044603","volume":"7","author":"F Safdie","year":"2012","unstructured":"Safdie F, Brandhorst S, Wei M, Wang W, Lee C, Hwang S, et al. Fasting enhances the response of Glioma to chemo- and radiotherapy. PLoS One. 2012;7(9):e44603.","journal-title":"PLoS One"},{"issue":"124","key":"7041_CR4","first-page":"124ra27","volume":"4","author":"C Lee","year":"2012","unstructured":"Lee C, Raffaghello L, Brandhorst S, Safdie FM, Bianchi G, Martin-Montalvo A, et al. Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy. Sci Transl Med. 2012;4(124):124ra27.","journal-title":"Sci Transl Med"},{"issue":"24","key":"7041_CR5","doi-asserted-by":"crossref","first-page":"8215","DOI":"10.1073\/pnas.0708100105","volume":"105","author":"L Raffaghello","year":"2008","unstructured":"Raffaghello L, Lee C, Safdie FM, Wei M, Madia F, Bianchi G, et al. Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proc Natl Acad Sci. 2008;105(24):8215\u201320.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"7041_CR6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cmet.2013.12.008","volume":"19","author":"VD Longo","year":"2014","unstructured":"Longo VD, Mattson MP. Fasting: molecular mechanisms and clinical applications. Cell Metab. 2014;19(2):181\u201392.","journal-title":"Cell Metab"},{"issue":"24","key":"7041_CR7","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMcibr1202395","volume":"366","author":"A Laviano","year":"2012","unstructured":"Laviano A, Rossi FF. Toxicity in chemotherapy--when less is more. N Engl J Med. 2012;366(24):2319\u201320.","journal-title":"N Engl J Med"},{"issue":"12","key":"7041_CR8","doi-asserted-by":"crossref","first-page":"988","DOI":"10.18632\/aging.100114","volume":"1","author":"FM Safdie","year":"2009","unstructured":"Safdie FM, Dorff T, Quinn D, Fontana L, Wei M, Lee C, et al. Fasting and cancer treatment in humans: a case series report. Aging. 2009;1(12):988\u20131007.","journal-title":"Aging."},{"key":"7041_CR9","doi-asserted-by":"crossref","unstructured":"de Groot S, Vreeswijk MP, Welters MJ, Gravesteijn G, Boei JJ, Jochems A, et al. The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study. BMC Cancer. 2015;15(1).","DOI":"10.1186\/s12885-015-1663-5"},{"issue":"1","key":"7041_CR10","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1186\/s12885-018-4353-2","volume":"18","author":"SP Bauersfeld","year":"2018","unstructured":"Bauersfeld SP, Kessler CS, Wischnewsky M, Jaensch A, Steckhan N, Stange R, et al. The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot study. BMC Cancer. 2018;18(1):476.","journal-title":"BMC Cancer"},{"key":"7041_CR11","doi-asserted-by":"crossref","unstructured":"Dorff TB, Groshen S, Garcia A, Shah M, Tsao-Wei D, Pham H, et al. Safety and feasibility of fasting in combination with platinum-based chemotherapy. BMC Cancer. 2016;16(1).","DOI":"10.1186\/s12885-016-2370-6"},{"issue":"4","key":"7041_CR12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000066032","volume":"9","author":"A Michalsen","year":"2002","unstructured":"Michalsen A, Weidenhammer W, Melchart D, Langhorst J, Saha J, Dobos G. Kurzzeitiges therapeutisches Fasten in der Behandlung von chronischen Schmerz- und Ersch\u00f6pfungssyndromen \u2013 Vertr\u00e4glichkeit und Nebenwirkungen mit und ohne begleitende Mineralstofferg\u00e4nzung. Complement Med Res. 2002;9(4):221\u20137.","journal-title":"Complement Med Res"},{"issue":"4","key":"7041_CR13","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/acm.2005.11.601","volume":"11","author":"A Michalsen","year":"2005","unstructured":"Michalsen A, Hoffmann B, Moebus S, B\u00e4cker M, Langhorst J, Dobos GJ. Incorporation of fasting therapy in an integrative medicine ward: evaluation of outcome, safety, and effects on lifestyle adherence in a large prospective cohort study. J Altern Complement Med N Y N. 2005;11(4):601\u20137.","journal-title":"J Altern Complement Med N Y N"},{"issue":"1","key":"7041_CR14","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cmet.2015.05.012","volume":"22","author":"S Brandhorst","year":"2015","unstructured":"Brandhorst S, Choi IY, Wei M, Cheng CW, Sedrakyan S, Navarrete G, et al. A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and Healthspan. Cell Metab. 2015 Jul 7;22(1):86\u201399.","journal-title":"Cell Metab"},{"issue":"3","key":"7041_CR15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.plefa.2003.09.007","volume":"70","author":"RL Veech","year":"2004","unstructured":"Veech RL. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids. 2004 Mar;70(3):309\u201319.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"5","key":"7041_CR16","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/ajcn\/83.5.1055","volume":"83","author":"CS Johnston","year":"2006","unstructured":"Johnston CS, Tjonn SL, Swan PD, White A, Hutchins H, Sears B. Ketogenic low-carbohydrate diets have no metabolic advantage over nonketogenic low-carbohydrate diets. Am J Clin Nutr. 2006;83(5):1055\u201361.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"7041_CR17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/ajcn\/87.1.44","volume":"87","author":"AM Johnstone","year":"2008","unstructured":"Johnstone AM, Horgan GW, Murison SD, Bremner DM, Lobley GE. Effects of a high-protein ketogenic diet on hunger, appetite, and weight loss in obese men feeding ad libitum. Am J Clin Nutr. 2008;87(1):44\u201355.","journal-title":"Am J Clin Nutr"},{"issue":"7","key":"7041_CR18","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/ejcn.2013.90","volume":"67","author":"P Sumithran","year":"2013","unstructured":"Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A, et al. Ketosis and appetite-mediating nutrients and hormones after weight loss. Eur J Clin Nutr. 2013;67(7):759\u201364.","journal-title":"Eur J Clin Nutr"},{"issue":"2","key":"7041_CR19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/ajcn\/51.2.241","volume":"51","author":"MD Mifflin","year":"1990","unstructured":"Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO. A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr. 1990;51(2):241\u20137.","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"7041_CR20","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3109\/00016349.2010.512070","volume":"89","author":"KV Calsteren","year":"2010","unstructured":"Calsteren KV, Verbesselt R, Ottevanger N, Halaska M, Heyns L, Bree RV, et al. Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study. Acta Obstet Gynecol Scand. 2010;89(10):1338\u201345.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"8","key":"7041_CR21","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/ejcn.2013.116","volume":"67","author":"A Paoli","year":"2013","unstructured":"Paoli A, Rubini A, Volek JS, Grimaldi KA. Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. Eur J Clin Nutr. 2013;67(8):789\u201396.","journal-title":"Eur J Clin Nutr"},{"key":"7041_CR22","unstructured":"National Institutes of Health, National Cancer Institute, editors. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 [Internet]. 2009. Available from: http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE."},{"issue":"5","key":"7041_CR23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. JNCI J Natl Cancer Inst. 1993;85(5):365\u201376.","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"8","key":"7041_CR24","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.ejca.2005.02.012","volume":"41","author":"TJ Postma","year":"2005","unstructured":"Postma TJ, Aaronson NK, Heimans JJ, Muller MJ, Hildebrand JG, Delattre JY, et al. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer. 2005;41(8):1135\u20139.","journal-title":"Eur J Cancer"},{"issue":"2","key":"7041_CR25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","volume":"13","author":"SB Yellen","year":"1997","unstructured":"Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the functional assessment of Cancer therapy (FACT) measurement system. J Pain Symptom Manag. 1997 Feb 1;13(2):63\u201374.","journal-title":"J Pain Symptom Manag"},{"issue":"6","key":"7041_CR26","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1159\/000357602","volume":"20","author":"F Wilhelmi de Toledo","year":"2013","unstructured":"Wilhelmi de Toledo F, Buchinger A, Burggrabe H, H\u00f6lz G, Kuhn C, Lischka E, et al. Fasting therapy - an expert panel update of the 2002 consensus guidelines. Forsch Komplement\u00e4rmedizin Res Complement Med. 2013;20(6):434\u201343.","journal-title":"Forsch Komplement\u00e4rmedizin Res Complement Med"},{"issue":"5","key":"7041_CR27","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/annonc\/mdr412","volume":"23","author":"P Vici","year":"2012","unstructured":"Vici P, Brandi M, Giotta F, Foggi P, Schittulli F, Di Lauro L, et al. A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 study. Ann Oncol. 2012;23(5):1121\u20139.","journal-title":"Ann Oncol"},{"issue":"2","key":"7041_CR28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejon.2010.06.010","volume":"15","author":"A Coolbrandt","year":"2011","unstructured":"Coolbrandt A, den Heede KV, Vanhove E, Bom AD, Milisen K, Wildiers H. Immediate versus delayed self-reporting of symptoms and side effects during chemotherapy: does timing matter? Eur J Oncol Nurs. 2011;15(2):130\u20136.","journal-title":"Eur J Oncol Nurs"},{"issue":"10","key":"7041_CR29","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s11916-013-0368-1","volume":"17","author":"T Dalkara","year":"2013","unstructured":"Dalkara T, Kili\u00e7 K. How does fasting trigger migraine? A hypothesis. Curr Pain Headache Rep. 2013;17(10):368.","journal-title":"Curr Pain Headache Rep"},{"issue":"8","key":"7041_CR30","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.3390\/nu11081742","volume":"11","author":"C Di Lorenzo","year":"2019","unstructured":"Di Lorenzo C, Pinto A, Ienca R, Coppola G, Sirianni G, Di Lorenzo G, et al. A randomized double-blind, cross-over trial of very low-calorie diet in overweight migraine patients: a possible role for ketones? Nutrients. 2019;11(8):1742.","journal-title":"Nutrients."},{"issue":"1","key":"7041_CR31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/ene.12550","volume":"22","author":"C Di Lorenzo","year":"2015","unstructured":"Di Lorenzo C, Coppola G, Sirianni G, Di Lorenzo G, Bracaglia M, Di Lenola D, et al. Migraine improvement during short lasting ketogenesis: a proof-of-concept study. Eur J Neurol. 2015;22(1):170\u20137.","journal-title":"Eur J Neurol"},{"key":"7041_CR32","doi-asserted-by":"crossref","unstructured":"Gross EC, Klement RJ, Schoenen J, D\u2019Agostino DP, Fischer D. Potential Protective Mechanisms of Ketone Bodies in Migraine Prevention. Nutrients. 2019;11(4).","DOI":"10.3390\/nu11040811"},{"issue":"6","key":"7041_CR33","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.stem.2014.04.014","volume":"14","author":"C-W Cheng","year":"2014","unstructured":"Cheng C-W, Adams GB, Perin L, Wei M, Zhou X, Lam BS, et al. Prolonged fasting reduces IGF-1\/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression. Cell Stem Cell. 2014;14(6):810\u201323.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"7041_CR34","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1245\/s10434-019-07186-1","volume":"26","author":"G Jomrich","year":"2019","unstructured":"Jomrich G, Hollenstein M, John M, Ristl R, Paireder M, Kristo I, et al. High mean corpuscular volume predicts poor outcome for patients with Gastroesophageal adenocarcinoma. Ann Surg Oncol. 2019;26(4):976\u201385.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"7041_CR35","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3892\/mco.2016.827","volume":"4","author":"P Zhang","year":"2016","unstructured":"Zhang P, Zong Y, Liu M, Tai Y, Cao Y, Hu C. Prediction of outcome in breast cancer patients using test parameters from complete blood count. Mol Clin Oncol. 2016;4(6):918\u201324.","journal-title":"Mol Clin Oncol"},{"key":"7041_CR36","doi-asserted-by":"crossref","unstructured":"de Groot S, Pijl H, van der Hoeven JJM, Kroep JR. Effects of short-term fasting on cancer treatment. J Exp Clin Cancer Res CR. 2019;38.","DOI":"10.1186\/s13046-019-1189-9"},{"issue":"4","key":"7041_CR37","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1158\/0008-5472.CAN-09-3228","volume":"70","author":"C Lee","year":"2010","unstructured":"Lee C, Safdie FM, Raffaghello L, Wei M, Madia F, Parrella E, et al. Reduced levels of IGF-I mediate differential protection of Normal and Cancer cells in response to fasting and improve chemotherapeutic index. Cancer Res. 2010;70(4):1564\u201372.","journal-title":"Cancer Res"},{"key":"7041_CR38","doi-asserted-by":"crossref","unstructured":"Urbain P, Strom L, Morawski L, Wehrle A, Deibert P, Bertz H. Impact of a 6-week non-energy-restricted ketogenic diet on physical fitness, body composition and biochemical parameters in healthy adults. Nutr Metab. 2017;14(1).","DOI":"10.1186\/s12986-017-0175-5"},{"issue":"1","key":"7041_CR39","doi-asserted-by":"crossref","first-page":"e0209353","DOI":"10.1371\/journal.pone.0209353","volume":"14","author":"FW de Toledo","year":"2019","unstructured":"de Toledo FW, Grundler F, Bergouignan A, Drinda S, Michalsen A. Safety, health improvement and well-being during a 4 to 21-day fasting period in an observational study including 1422 subjects. PLoS One. 2019;14(1):e0209353.","journal-title":"PLoS One"},{"issue":"2","key":"7041_CR40","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1172\/JCI107941","volume":"55","author":"MH Sigler","year":"1975","unstructured":"Sigler MH. The mechanism of the natriuresis of fasting. J Clin Invest. 1975;55(2):377\u201387.","journal-title":"J Clin Invest"},{"issue":"5","key":"7041_CR41","first-page":"379","volume":"137","author":"PR Kerndt","year":"1982","unstructured":"Kerndt PR, Naughton JL, Driscoll CE, Loxterkamp DA. Fasting: the history, Pathophysiology and Complications. West J Med. 1982;137(5):379\u201399.","journal-title":"West J Med"},{"issue":"02","key":"7041_CR42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4149\/BLL_2018_020","volume":"119","author":"V Mojto","year":"2018","unstructured":"Mojto V, Gvozdjakova A, Kucharska J, Rausova Z, Vancova O, Valuch J. Effects of complete water fasting and regeneration diet on kidney function, oxidative stress and antioxidants. Bratisl Med J. 2018;119(02):107\u201311.","journal-title":"Bratisl Med J"},{"issue":"14","key":"7041_CR43","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1080\/15384101.2015.1044170","volume":"14","author":"SA Huisman","year":"2015","unstructured":"Huisman SA, Bijman-Lagcher W, IJzermans JN, Smits R, de Bruin RW. Fasting protects against the side effects of irinotecan but preserves its anti-tumor effect in Apc15lox mutant mice. Cell Cycle. 2015;14(14):2333\u20139.","journal-title":"Cell Cycle"},{"issue":"1","key":"7041_CR44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/ajcn\/68.1.12","volume":"68","author":"OE Owen","year":"1998","unstructured":"Owen OE, Smalley KJ, D\u2019Alessio DA, Mozzoli MA, Dawson EK. Protein, fat, and carbohydrate requirements during starvation: anaplerosis and cataplerosis. Am J Clin Nutr. 1998;68(1):12\u201334.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"7041_CR45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jamda.2018.11.021","volume":"20","author":"NEP Deutz","year":"2019","unstructured":"Deutz NEP, Ashurst I, Ballesteros MD, Bear DE, Cruz-Jentoft AJ, Genton L, et al. The underappreciated role of low muscle mass in the Management of Malnutrition. J Am Med Dir Assoc. 2019;20(1):22\u20137.","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"7041_CR46","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12877-017-0505-5","volume":"17","author":"VD Pierik","year":"2017","unstructured":"Pierik VD, Meskers CGM, Van Ancum JM, Numans ST, Verlaan S, Scheerman K, et al. High risk of malnutrition is associated with low muscle mass in older hospitalized patients - a prospective cohort study. BMC Geriatr. 2017;17(1):118.","journal-title":"BMC Geriatr"},{"key":"7041_CR47","doi-asserted-by":"crossref","unstructured":"Gupta D, Lammersfeld CA, Vashi PG, King J, Dahlk SL, Grutsch JF, et al. Bioelectrical impedance phase angle as a prognostic indicator in breast cancer. BMC Cancer. 2008;8(1).","DOI":"10.1186\/1471-2407-8-249"},{"issue":"3","key":"7041_CR48","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3945\/ajcn.2010.29215","volume":"92","author":"K Norman","year":"2010","unstructured":"Norman K, Stob\u00e4us N, Zocher D, Bosy-Westphal A, Szramek A, Scheufele R, et al. Cut off percentiles of bioelectrical phase angle predict functionality, quality of life, and mortality in patients with cancer. Am J Clin Nutr. 2010;92(3):612\u20139.","journal-title":"Am J Clin Nutr"},{"key":"7041_CR49","doi-asserted-by":"crossref","unstructured":"Aslant\u00fcrk \u00d6S. In vitro cytotoxicity and cell viability assays: principles, advantages, and disadvantages. Genotoxicity Predict Risk Actual World 2017;.","DOI":"10.5772\/intechopen.71923"},{"issue":"4","key":"7041_CR50","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/0148607106030004309","volume":"30","author":"A Bosy-Westphal","year":"2006","unstructured":"Bosy-Westphal A, Danielzik S, D\u00f6rh\u00f6fer R-P, Later W, Wiese S, M\u00fcller MJ. Phase angle from bioelectrical impedance analysis: population reference values by age, sex, and body mass index. J Parenter Enter Nutr. 2006;30(4):309\u201316.","journal-title":"J Parenter Enter Nutr"},{"issue":"1","key":"7041_CR51","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00277-012-1573-4","volume":"92","author":"P Urbain","year":"2013","unstructured":"Urbain P, Birlinger J, Ihorst G, Biesalski H-K, Finke J, Bertz H. Body mass index and bioelectrical impedance phase angle as potentially modifiable nutritional markers are independent risk factors for outcome in allogeneic hematopoietic cell transplantation. Ann Hematol. 2013;92(1):111\u20139.","journal-title":"Ann Hematol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07041-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-07041-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07041-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T19:32:37Z","timestamp":1624303957000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07041-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,22]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7041"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07041-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-15992\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,22]]},"assertion":[{"value":"19 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Ethics Commission of Albert-Ludwig University Freiburg (313\/16). All subjects provided written informed consent prior to participation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"578"}}